1	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
2	virus-transforming	virus-transforming	_	_	_	_	_	_	_
3	protein	protein	_	_	_	_	_	_	_
4	latent	latent	_	_	_	_	_	_	_
5	infection	infection	_	_	_	_	_	_	_
6	membrane	membrane	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	1	1	_	_	_	_	_	_	_
9	activates	activate	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	pathway	pathway	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	includes	include	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	NF-kappaB-inducing	NF-kappaB-inducing	_	_	_	_	_	_	_
20	kinase	kinase	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	IkappaB	IkappaB	_	_	_	_	_	_	_
24	kinases	kinase	_	_	_	_	_	_	_
25	IKKalpha	IKKalpha	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	IKKbeta	IKKbeta	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	oncoprotein	oncoprotein	_	_	_	_	_	_	_
5	latent	latent	_	_	_	_	_	_	_
6	infection	infection	_	_	_	_	_	_	_
7	membrane	membrane	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	1	1	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	LMP1	lmp1	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	constitutively	constitutively	_	_	_	_	_	_	_
16	aggregated	aggregate	_	_	_	_	_	_	_
17	pseudo-tumor	pseudo-tumor	_	_	_	_	_	_	_
18	necrosis	necrosis	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	receptor	receptor	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	TNFR	TNFR	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	activates	activate	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
29	through	through	_	_	_	_	_	_	_
30	two	two	_	_	_	_	_	_	_
31	sites	site	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	its	its	_	_	_	_	_	_	_
34	C-terminal	c-terminal	_	_	_	_	_	_	_
35	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
36	domain	domain	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	site	site	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	similar	similar	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	activated	activate	_	_	_	_	_	_	_
7	TNFRII	TNFRII	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	associating	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	TNFR-associated	tnfr-associated	_	_	_	_	_	_	_
12	factors	factor	_	_	_	_	_	_	_
13	TRAF1	TRAF1	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	TRAF2	TRAF2	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	second	second	_	_	_	_	_	_	_
20	site	site	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	similar	similar	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	TNFRI	TNFRI	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	associating	associate	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	TNFRI	TNFRI	_	_	_	_	_	_	_
30	death	death	_	_	_	_	_	_	_
31	domain	domain	_	_	_	_	_	_	_
32	interacting	interact	_	_	_	_	_	_	_
33	protein	protein	_	_	_	_	_	_	_
34	TRADD	TRADD	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	TNFRI	TNFRI	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	recently	recently	_	_	_	_	_	_	_
5	shown	show	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	activate	activate	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	through	through	_	_	_	_	_	_	_
10	association	association	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	TRADD	TRADD	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	RIP	RIP	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	TRAF2	traf2	_	_	_	_	_	_	_
18	;	;	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	NF-kappaB-inducing	NF-kappaB-inducing	_	_	_	_	_	_	_
23	kinase	kinase	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	NIK	NIK	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	;	;	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	IkappaB	IkappaB	_	_	_	_	_	_	_
32	alpha	alpha	_	_	_	_	_	_	_
33	kinases	kinase	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	IKKalpha	IKKalpha	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	IKKbeta	IKKbeta	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	;	;	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	phosphorylation	phosphorylation	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	IkappaB	IkappaB	_	_	_	_	_	_	_
44	alpha	alpha	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	IkappaB	IkappaB	_	_	_	_	_	_	_
2	alpha	alpha	_	_	_	_	_	_	_
3	phosphorylation	phosphorylation	_	_	_	_	_	_	_
4	on	on	_	_	_	_	_	_	_
5	Ser-32	Ser-32	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	Ser-36	Ser-36	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	followed	follow	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	its	its	_	_	_	_	_	_	_
12	degradation	degradation	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	show	show	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	LMP1	LMP1	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	each	each	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	its	its	_	_	_	_	_	_	_
17	effector	effector	_	_	_	_	_	_	_
18	sites	site	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	mediated	mediate	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	pathway	pathway	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	includes	include	_	_	_	_	_	_	_
26	NIK	NIK	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	IKKalpha	IKKalpha	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	IKKbeta	IKKbeta	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Dominant	dominant	_	_	_	_	_	_	_
2	negative	negative	_	_	_	_	_	_	_
3	mutants	mutant	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NIK	NIK	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	IKKalpha	IKKalpha	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	IKKbeta	IKKbeta	_	_	_	_	_	_	_
11	substantially	substantially	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	LMP1	LMP1	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	each	each	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	its	its	_	_	_	_	_	_	_
22	effector	effector	_	_	_	_	_	_	_
23	sites	site	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

